NASDAQ:QTNT Quotient (QTNT) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free QTNT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.19▼$0.8052-Week Range N/AVolume5.81 million shsAverage Volume437,886 shsMarket Capitalization$980,000.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Quotient alerts: Email Address Ad WealthPressThe system that called 2023’s top 7 stocks is at it again…Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! About Quotient Stock (NASDAQ:QTNT)Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ SDS Microarray that is designed as a serological disease screening microarray comprised assays to detect cytomegalovirus and Syphilis; MosaiQ MDS Microarray that is designed as a molecular disease screening microarray test for donor red cells or source plasma; MosaiQ IH Microarray as a blood grouping microarray; MosaiQ Autoimmune Microarray; MosaiQ COVID-19; and MosaiQ IH3 Microarray. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.Read More Ad Wealthpin ProOne trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? Well, then you should click here to see this free training. QTNT Stock News HeadlinesSeptember 5, 2023 | fool.comQuotient (NASDAQ: QTNT)November 16, 2022 | finance.yahoo.comQuotient Second Quarter 2023 Earnings: Revenues Miss ExpectationsApril 24, 2024 | Wealthpin Pro (Ad)One trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? November 2, 2022 | finance.yahoo.comQuotient Limited Announces Reverse Stock Split Effective TodayOctober 20, 2022 | techcrunch.comGlobalFair secures new cash to simplify procuring construction materials - TechCrunchOctober 19, 2022 | forbes.comTransforming Uncertainty Into Possibility - ForbesOctober 18, 2022 | benzinga.comQuotient Sciences Completes Major Expansion of Drug Substance Manufacturing Facility - BenzingaOctober 15, 2022 | finance.yahoo.comH.I.G. Acquisition Corp. Announces Redemption of Class A Ordinary Shares - Yahoo FinanceApril 24, 2024 | Wealthpin Pro (Ad)One trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? September 29, 2022 | prnewswire.comOxilio and Quotient Sciences Announce Regulatory Approval for Oxilio's OXL001 Development Program - PR NewswireSeptember 28, 2022 | finance.yahoo.comInsiders who bought in the last 12 months lose an additional US$231k as Quotient Limited (NASDAQ:QTNT) drops to US$20m - Yahoo FinanceSeptember 28, 2022 | businesswire.comQuotient's Omnichannel Measurement Now Combines Promotions with Media to Ensure Every Shoppable Moment is Attributable - Business WireSeptember 28, 2022 | finance.yahoo.comInsiders who bought in the last 12 months lose an additional US$231k as Quotient Limited (NASDAQ:QTNT) drops to US$20mSeptember 26, 2022 | bizjournals.comWhat are the most unique jobs in Buffalo, New York? - Buffalo Business First - The Business JournalsSeptember 23, 2022 | washingtonpost.com‘Catherine Called Birdy’: Lena Dunham's Y.A. take on the patriarchy - The Washington PostSeptember 22, 2022 | prnewswire.comQuotient Sciences Expands UK Facilities to Support the Delivery of Translational Pharmaceutics® Programs - PR NewswireSeptember 19, 2022 | washingtonpost.comBritish royal family has inspired souvenir collectors for decades - The Washington PostSeptember 12, 2022 | bizjournals.comThese are the 33 highest-paying jobs in the Buffalo metro area - Buffalo Business First - The Business JournalsSeptember 9, 2022 | benzinga.comThinking about buying stock in Nio, Quotient, Mogu, Rivian Automotive, or LYFT?September 9, 2022 | finance.yahoo.comThe Best (and Worst) Cities for People Without a College Degree - Yahoo FinanceSeptember 8, 2022 | globenewswire.comQuotient Limited Selected to Join the World Economic Forum New Champions Community - GlobeNewswireSeptember 8, 2022 | finance.yahoo.comQuotient Limited Selected to Join the World Economic Forum New Champions CommunitySeptember 7, 2022 | gurufocus.comUsing the Rule of 40 to Find Growth Opportunities - GuruFocus.comSeptember 7, 2022 | benzinga.comMIDWEST ENERGY EM (MEEC), Quotient Ltd (QTNT) – Quotient And 2 Other Stocks Under $1 Insiders Are Buying - BenzingaSeptember 1, 2022 | bizjournals.comThe key to success is AQ. Does your organization have it? - The Business JournalsAugust 31, 2022 | washingtonpost.comOpinion | Here's why the Trump GOP's crazy quotient is expanding - The Washington PostAugust 31, 2022 | benzinga.comHCW Biologics Inc (HCWB), Quotient Technology (QUOT) – Smith Micro Software And 3 Other Stocks Under $3 I - BenzingaSee More Headlines Receive QTNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quotient and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/05/2021Today4/24/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryN/A Current SymbolNASDAQ:QTNT CUSIPN/A CIK1596946 Webwww.quotientbd.com Phone(122) 716-9800FaxN/AEmployees426Year Founded2008Profitability EPS (Most Recent Fiscal Year)($53.21) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-125,130,000.00 Net Margins-413.55% Pretax Margin-411.03% Return on EquityN/A Return on Assets-88.21% Debt Debt-to-Equity RatioN/A Current Ratio1.79 Quick Ratio1.36 Sales & Book Value Annual Sales$38.51 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($56.17) per share Price / BookN/AMiscellaneous Outstanding Shares2,580,000Free Float2,309,000Market Cap$980,000.00 OptionableOptionable Beta2.32 Social Links 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Manuel O. Mendez (Age 54)CEO & Director Comp: $10.22MMr. Ali Kiboro (Age 47)Chief Financial Officer Comp: $798.9kMr. Mohammad El Khoury (Age 62)Chief Commercial Officer Comp: $544.83kMs. Vittoria Bonasso (Age 46)Head of Fin., Group Controller & Principal Accounting Officer Dr. Michael HausmannChief Technology OfficerDr. Christine GinocchioChief Scientific & Medical OfficerMs. Viviane MontarnalHead of Legal Affairs & ComplianceMs. Hyatt Antognini-AminHead of Corp. CommunicationsMr. Christian Albrich (Age 58)Chief People Officer Mr. Esteban UriarteChief Manufacturing Operations OfficerMore ExecutivesKey CompetitorsVirax Biolabs GroupNASDAQ:VRAXNavidea BiopharmaceuticalsNYSE:NAVB9 Meters BiopharmaNASDAQ:NMTRBiodexa PharmaceuticalsNASDAQ:BDRXScinai ImmunotherapeuticsNASDAQ:SCNIView All Competitors QTNT Stock Analysis - Frequently Asked Questions How were Quotient's earnings last quarter? Quotient Limited (NASDAQ:QTNT) released its quarterly earnings data on Thursday, August, 5th. The company reported ($9.60) earnings per share for the quarter, beating the consensus estimate of ($10.40) by $0.80. The business earned $9.09 million during the quarter, compared to analyst estimates of $9.10 million. When did Quotient's stock split? Quotient's stock reverse split on Thursday, November 3rd 2022. The 1-40 reverse split was announced on Thursday, November 3rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, November 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. What other stocks do shareholders of Quotient own? Based on aggregate information from My MarketBeat watchlists, some companies that other Quotient investors own include VBI Vaccines (VBIV), Inovio Pharmaceuticals (INO), Verastem (VSTM), Cidara Therapeutics (CDTX), Dynavax Technologies (DVAX), Gilead Sciences (GILD), SCYNEXIS (SCYX), Novavax (NVAX), Ocular Therapeutix (OCUL) and Sorrento Therapeutics (SRNE). This page (NASDAQ:QTNT) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss RatingsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quotient Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.